You are here

P&T News

January 18

Agency seeks comments on draft guidelines
Findings raise concern about money’s influence on evidence base
Controversial topic gets spotlight at Critical Care Congress
Treatment controls cataplexy in patients with narcolepsy

January 17

Phase 2/3 trial evaluates dopamine/norepinephrine reuptake inhibitor
President-elect takes aim at high drug prices
Drug makers “game” the system, report finds

January 13

Abnormal readings for an individual could suggest possible illness
Demographic, environmental, economic, and social factors may play a part
Insurance claims citing type-2 diabetes more than doubled in youth from 2011 to 2015
Meeting aims to support relationships, cooperation, and joint investigations
National Academies committee reviews the most recent research

January 12

House of Representatives expected to vote this week
Impax autoinjector has a cash price 80% lower than Mylan’s EpiPen
Better patient education, monitoring, and early lifestyle changes may help
The investigational therapy was added to standard of care
The initiative aims to leverage blockchain technology to improve public health